Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 2 days agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 3 days agoPharmaceutical company Moderna has announced that a combination vaccine it has been developing...
FDA modifies strain recommendation for fall COVID vaccine amid variant shifts, uptick in cases
Center for Infectious Disease Research and Policy· 50 minutes agoOn June 5, the FDA's vaccine advisory group recommended a switch to the JN.1 variant, though it held...
FDA reverses course, calls for vaccines for fall 2024 to target newer COVID-19 strain
AOL· 2 hours agoThe Food and Drug Administration provided updated guidance for COVID-19 vaccine makers, calling for...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
Morningstar· 4 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID ...
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 10 hours agoIn March this year, the company reported positive interim immunogenicity data from the vaccine...
CyanVac secures funding for Phase IIb intranasal Covid-19 vaccine trial
Clinical Trials Arena via Yahoo Finance· 8 hours agoCyanVac and its affiliate Blue Lake Biotechnology are developing the single-dose, intranasal vaccine...
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 1 day agoThe CDC reported last week that COVID-19 infections are “growing or likely growing in 30 states and...
A Combined Flu and COVID-19 Shot May Be Coming
Time via AOL· 4 days agoBoth of the shots used in the study are experimental. The COVID-19 portion relies on a slightly different form of SARS-CoV-2’s spike ...
Moderna says new-generation COVID vaccine more effective than Spikevax in adults 18 and over
Morningstar· 1 day ago"Today's vaccine efficacy data are consistent with the previously announced immunogenicity results from the study, which showed that mRNA-1283 had higher neutralizing antibody ...